However, some tumors can evade immunosurveillance through a variety of mechanisms, such as downregulating the expression of tumor antigens and major histocompatibility complex (MHC) molecules, expressing immune inhibitory proteins, and accumulating specific metabolites [9]. This evidence concerns the gene HLA-C and neoplasm.